Proyectos de ley › 89.ª Asamblea General
HSB 690
Temas:Health care
Dónde está ahora
- Hecho: Presentado9 de febrero de 2022
- Hecho: Subcomité9 de febrero de 2022
- Hecho: Comité de la Cámara17 de febrero de 2022
- Se saltó: Lo aprueba la CámaraSigue como HF 2539
- Sigue: Comité del Senado
- Sigue: Lo aprueba el Senado
- Sigue: A gobernador(a)
- Sigue: Firmado como ley
Ahora es HF 2539 → Sigue avanzando con el número nuevo. Ir a HF 2539 ¿Qué es el embudo (funnel)?
Qué contiene
Resumen con IA Iowa will create a new advisory committee to help the Department of Public Health decide which health conditions should be tested for in newborn screenings. This group of experts and parents will recommend adding new tests to the program and checking if the current tests are working well. The Department of Public Health must then follow these recommendations and send a yearly report to the state legislature about the program's progress. (Todavía no está traducido al español.)1
Lea la explicación oficial (en inglés)
This bill relates to newborn screenings. The bill establishes, in Code, the congenital and inherited disorders advisory committee (advisory committee), which currently is established in administrative rules. The bill provides, as is provided in administrative rules, that the advisory committee is established to assist the center for congenital and inherited disorders (center) and the department of public health (DPH) in matters relating to genetic and genomic health care services for all Iowans, that the members of the advisory committee shall be appointed by the director of public health, that the members shall include persons with relevant expertise and interest including parent representatives, and that one of the duties of the advisory committee is to assist the center and DPH in designating the conditions to be included in the newborn screening and in regularly evaluating the effectiveness and appropriateness of the newborn screening. _____ addition of a new condition to the federal recommended uniform screening panel, the advisory committee shall consider and make a recommendation to DPH regarding inclusion of the new condition in the newborn screening, including current newborn screening capacity to screen for the new condition and the resources necessary to screen for the new condition going forward. If the advisory committee recommends inclusion of a new condition, DPH shall ensure that the new condition is included in the newborn screening within months of receipt of the recommendation, subject to the provision of necessary newborn screening capacity and resources. The bill requires DPH to submit an annual report to the general assembly by December 31, regarding the current conditions included in the newborn screening, any new conditions currently under consideration or recommended by the advisory committee for inclusion in the newborn screening, any new conditions considered but not recommended by the advisory committee in the prior 12-month period and the reason for not recommending any such conditions, any departmental request for additional newborn screening program capacity or resources necessitated by the inclusion of a recommended new condition in the newborn screening, and any delay and the reason for the delay by the advisory committee or DPH in complying with the specified time frames for considering and recommending or adding a new condition to the newborn screening. The bill also changes references to “newborn metabolic screening” or “metabolic newborn screening” to “newborn screening”.
Texto completo del proyecto (en inglés) · Qué cambió antes de aprobarse2
House subcommittee
Named February 9, 2022. On February 10, 2022 it recommended amendment and passage. Vote Total: 3-0.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
Nota fiscal
Resumen con IA This bill requires Iowa to include all conditions from the federal recommended uniform screening panel in newborn screenings and requires the Department of Public Health to submit an annual report on these screenings. The State Hygienic Laboratory estimates initial startup costs of approximately $2.1 million and annual operating costs of approximately $714,000. These changes would increase the newborn screening fee from $122 to $141.80. (en inglés)3
Lea la nota fiscal (en inglés)
Description
Senate File 2345 relates to health screenings performed on newborns born in Iowa to discover congenital or inherited disorders. The Bill first codifies the Congenital and Inherited Disorders Advisory Committee (CIDAC) currently established in 641 IAC 4.1. The Bill requires that all conditions currently included in the federal recommended uniform screening panel (RUSP) be included in newborn screenings in Iowa, and that within 12 months of an addition of a condition to the RUSP, the CIDAC must review the addition and make a recommendation to the Iowa Department of Public Health (DPH) regarding the inclusion of the new condition in Iowa’s newborn screening panel. If the CIDAC recommends inclusion of the new condition, the DPH is then directed to ensure that the new condition is included in the State’s screening panel within 18 months of receiving the recommendation.
The Bill also requires the DPH to submit an annual report to the General Assembly by December 31 regarding current conditions included in the State’s screening panel, any new conditions currently under consideration or recommendation by the CIDAC, and any conditions considered that did not receive a recommendation to be included with the reason for not being included. Senate File 2345 also directs the State Hygienic Laboratory (SHL) to establish the newborn screening fee schedule to support the costs of the program.
Background
There are currently 35 congenital and inherited disorders included on the RUSP, 32 of which are currently being tested for in the Iowa newborn screening. The three disorders included on the RUSP that are not being screened for in Iowa are Pompe disease, Mucopolysaccharidosis type 1 (MPS-1), and X-linked adrenoleukodystrophy (X-ALD).
Parents of newborns are currently charged a fee of $122 to cover the costs of the screening tests unless they decline to have their child tested. This fee has not increased in the past seven years.
Assumptions
In order for the SHL to be able to test for the three conditions in the RUSP that are not currently being tested for, the SHL will need additional testing equipment, test development and validation, training, information technology changes, and quality management system adjustments.
Fiscal Impact
The SHL reports that initial startup costs for the three additional tests would be approximately $2.1 million. Operating costs to continue administering the three additional tests are estimated to be approximately $714,000 per year. Increasing the annual operating costs of the newborn screenings would result in a $19.80 increase to the newborn screening fee, which would raise the fee from $122 to $141.80.
Sources
- Department of Public Health
- Board of Regents
- LSA calculations
- /a/ Holly M. Lyons
- June 30, 2022
- The fiscal note for this Bill was prepared pursuant to Joint Rule 17 and the Iowa Code. Data used in
- developing this fiscal note is available from the Fiscal Services Division of the Legislative Services
- Agency upon request.
El cálculo no cambió
4- Final Fiscal Note — Newborn Screening · 30 de junio de 2022 · $714,000
- Newborn Screening · 8 de marzo de 2022 · $714,000
- Newborn Screening · 7 de marzo de 2022 · $714,000
Lo que cambia del Código de Iowa (Iowa Code)
Crea§136A.3A
Cabildeo
13 a favor · 0 en contra · 12 indecisos · Quiénes →
Family tree
Study bill
89th General Assembly